Announcements Trials
Browse Landscape

Status

Unknown 10Completed 7Terminated 2Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 5NIH 1INDUSTRY 1

Study Type

Interventional 174Observational 7

Sponsor

Cancer Type

Breast 6Other neoplasm 1Other 1Endocrine 1

Conditions

Breast Neoplasms 6Precancerous Conditions 1Obesity 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Hot Flashes 1Depression 1Carcinoma, Intraductal, Noninfiltrating 1Arthralgia 1

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 58Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Reverse Transcriptase Polymerase Chain Reaction 39Bevacizumab 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Therapeutics 24Neoadjuvant Therapy 24Hepatectomy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Completed × Observational × Tamoxifen × Clear all
NCT06982313 2026-03-11

Babytam long

Ente Ospedaliero Ospedali Galliera

Completed
1,545 enrolled
BreastOther neoplasm

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Precancerous Conditions

NCT00667121 2025-02-14

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Mayo Clinic

Completed
88 enrolled
Breast

Breast Neoplasms, Depression, Hot Flashes

NCT02753686 2023-02-15

Treat ER+ight

Novartis

Completed
440 enrolled
Endocrine

Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

NCT00900744 2017-08-25

A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6

Icahn School of Medicine at Mount Sinai

Completed
121 enrolled
Breast

Breast Neoplasms

NCT01896050 2016-06-28

LOGRIBMET

University of Michigan Rogel Cancer Center

Completed
115 enrolled 14 charts
BreastOther

Breast Neoplasms, Obesity, Arthralgia

NCT01169792 2010-07-26

Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients

Yonsei University

Completed
Breast

Breast Neoplasms

NCT00228930 2008-09-25

Tamoxifen Pharmacogenetics and Clinical Effects

National Institute of General Medical Sciences (NIGMS)

Completed
297 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡